Norma Hernández‐Pedro

1.7k total citations
50 papers, 1.3k citations indexed

About

Norma Hernández‐Pedro is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Norma Hernández‐Pedro has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Norma Hernández‐Pedro's work include Lung Cancer Treatments and Mutations (9 papers), Retinoids in leukemia and cellular processes (7 papers) and Immunotherapy and Immune Responses (7 papers). Norma Hernández‐Pedro is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Retinoids in leukemia and cellular processes (7 papers) and Immunotherapy and Immune Responses (7 papers). Norma Hernández‐Pedro collaborates with scholars based in Mexico, Colombia and Spain. Norma Hernández‐Pedro's co-authors include Óscar Arrieta, Julio Sotelo, Benjamín Pineda, Verónica Pérez de la Cruz, Pedro Barrios‐Bernal, Mario Orozco‐Morales, Edgar Rangel‐López, Diana Flores‐Estrada, Alejandro Avilés‐Salas and Luis Manuel Martínez-Barrera and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Norma Hernández‐Pedro

48 papers receiving 1.3k citations

Peers

Norma Hernández‐Pedro

ONCOL

IMMUN

PRM

Xia Zhao China

Hua You China

Iris C. Salaroglio Italy

Arnaud Monvoisin France

Zeng Fan China

Tao Guo China

Daniele Avanzato Italy

Tejaswitha Jairaj Naik United States

Lin Zhong China

Silvia Baldari Italy

Xia Zhao China

Norma Hernández‐Pedro

814 ×1.4

293 ×0.9

ONCOL

218 ×0.9

273 ×1.3

IMMUN

125 ×0.7

PRM

Citations per year, relative to Norma Hernández‐Pedro Norma Hernández‐Pedro (= 1×) peers Xia Zhao

Countries citing papers authored by Norma Hernández‐Pedro

Since Specialization

Citations

This map shows the geographic impact of Norma Hernández‐Pedro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Hernández‐Pedro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Hernández‐Pedro more than expected).

Fields of papers citing papers by Norma Hernández‐Pedro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Hernández‐Pedro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Hernández‐Pedro. The network helps show where Norma Hernández‐Pedro may publish in the future.

Co-authorship network of co-authors of Norma Hernández‐Pedro

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Hernández‐Pedro. A scholar is included among the top collaborators of Norma Hernández‐Pedro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Hernández‐Pedro. Norma Hernández‐Pedro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabrera‐Galeana, Paula, Santiago Ávila‐Ríos, Margarita Matías‐Florentino, et al.. (2025). Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 2021, 13, 6256. Cancers. 17(19). 3212–3212.

Arrieta, Óscar, Norma Hernández‐Pedro, Rosa María Álvarez-Gómez, et al.. (2024). Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung Cancer. 194. 107864–107864. 4 indexed citations

Hernández‐Pedro, Norma, Marisol Arroyo‐Hernández, Pedro Barrios‐Bernal, et al.. (2023). Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines. 11(10). 1612–1612. 1 indexed citations

Avilés‐Salas, Alejandro, Norma Hernández‐Pedro, Suraj Samtani, et al.. (2023). PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma. Frontiers in Oncology. 13. 1269029–1269029. 3 indexed citations

Barrios‐Bernal, Pedro, et al.. (2023). A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition. International Journal of Molecular Sciences. 24(5). 4331–4331. 5 indexed citations

Barrios‐Bernal, Pedro, Zyanya Lucía Zatarain-Barrón, Norma Hernández‐Pedro, et al.. (2022). Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. Pharmaceuticals. 15(7). 786–786. 8 indexed citations

Orozco‐Morales, Mario, Alejandro Avilés‐Salas, Norma Hernández‐Pedro, et al.. (2021). Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors. Journal of Immunology Research. 2021. 1–9. 12 indexed citations

Orozco‐Morales, Mario, Norma Hernández‐Pedro, Pedro Barrios‐Bernal, et al.. (2019). P1.20 S-allyl Cysteine Induces Cytotoxic Effects on Human NSCLC Cell Lines. Journal of Thoracic Oncology. 14(11). S1181–S1181. 1 indexed citations

Pineda, Benjamín, Verónica Pérez de la Cruz, Sergio Moreno‐Jiménez, et al.. (2019). Malignant Glioma Therapy by Vaccination with Irradiated C6 Cell-Derived Microvesicles Promotes an Antitumoral Immune Response. Molecular Therapy. 27(9). 1612–1620. 29 indexed citations

10.

Hernández‐Pedro, Norma, Giovanny Soca‐Chafre, Karol Carrillo‐Sánchez, et al.. (2019). Mutational profile by targeted next generation sequencing of non-small cell lung cancer in the Mexican population. Salud Pública de México. 61(3, may-jun). 308–308. 13 indexed citations

11.

Muñiz‐Hernández, Saé, Sara Huerta‐Yépez, Norma Hernández‐Pedro, et al.. (2016). Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer. International Journal of Clinical Oncology. 21(6). 1051–1061. 8 indexed citations

12.

Muñiz‐Hernández, Saé, et al.. (2015). Alterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications. Journal of Cancer Therapy. 6(8). 648–664. 5 indexed citations

13.

Orozco‐Morales, Mario, Francisco Javier Sánchez‐García, Norma Hernández‐Pedro, et al.. (2015). RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells. Cancer Cell International. 15(1). 57–57. 20 indexed citations

14.

Hernández‐Pedro, Norma, Vinicio Granados‐Soto, Graciela Ordóñez, et al.. (2014). Vitamin A increases nerve growth factor and retinoic acid receptor beta and improves diabetic neuropathy in rats. Translational research. 164(3). 196–201. 18 indexed citations

15.

Hernández‐Pedro, Norma, Edgar Rangel‐López, Verónica Pérez de la Cruz, et al.. (2013). Application of Nanoparticles on Diagnosis and Therapy in Gliomas. BioMed Research International. 2013. 1–20. 65 indexed citations

16.

Manoutcharian, Karen, Norma Hernández‐Pedro, Edgar Rangel‐López, et al.. (2013). Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma. Journal of Cancer Research and Clinical Oncology. 140(2). 291–301. 15 indexed citations

17.

Arrieta, Óscar, Claudia Haydée González-De la Rosa, Elena Aréchaga-Ocampo, et al.. (2010). Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 28(21). 3463–3471. 109 indexed citations

18.

Arrieta, Óscar, Luis Manuel Martínez-Barrera, Diana Flores‐Estrada, et al.. (2008). Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients: An Open Label Phase II Study. Journal of Thoracic Oncology. 3(8). 887–893. 22 indexed citations

19.

Arrieta, Óscar, Benjamín Pineda, Norma Hernández‐Pedro, et al.. (2008). Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. British Journal of Cancer. 99(1). 160–166. 60 indexed citations

20.

Arrieta, Óscar, et al.. (2005). Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice. European Journal of Clinical Investigation. 35(3). 201–207. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact